The Man Who Sued Facebook Is Bullish About the Platform
*By Conor White*
Though he sued Mark Zuckerberg for stealing the idea for Facebook, Divya Narendra said he's excited about the future of the social media giant, and sees Facebook as a good investment.
"If you have a long-term mindset, this is probably one of the cheapest stocks you can own," said Narendra in an interview Thursday with Cheddar's Kristen Scholer and Brad Smith. "On a price-to-earnings basis, or on a price-to-growth basis, really versus any other stock in this sort of large cap universe."
Narendra hit Zuckerberg with an intellectual property suit for allegedly stealing the idea for Facebook while the two were students at Harvard. They settled in 2009 for around $65 million ー $20 million in cash and 1.25 million Facebook shares. Despite that antagonistic history, Narendra is bullish on Zuckerberg's company.
"You saw a 15 to 20 percent drop in the stock off of bad PR, which is I think a solvable problem," said Narendra. "I guess that's how the markets work, but clearly an overreaction."
Narendra is the chief executive of SumZero, an investment website for professional investors.
For the full interview, [click here](https://cheddar.com/videos/facebook-looks-to-future-after-beating-earnings-expectations).
Ashley Gold, Axios' Tech/Policy reporter, discusses what the future of Google and search engines will look like after the tech giant faces an antitrust trial.
A labor rights group has alleged that Starbucks sourced coffee from a major Brazilian cooperative whose member farms were cited for keeping workers in slave-like conditions.
X, the social media platform owned by Trump adviser Elon Musk, is challenging the constitutionality of a Minnesota ban on using deepfakes to influence elections and harm candidates.
Seth Goldstein, Equity Strategist at Morningstar, breaks down Tesla's earnings report, talks Musk's future with the company and how stocks have responded.
Senior Health Correspondent for TIME, Alice Park, gives us a deeper look into how Eli Lilly's new pill orforglipron may change the healthcare industry.
Archer Aviation CEO Adam Goldstein talks about the advancements in electric air taxis and how his company is changing the future of air transportation. Watch!
